CSL - Ebit

Stock Price
97.96
Daily Change
0.70 0.72%
Monthly
-28.78%
Yearly
-59.49%
Q2 Forecast
96.11

CSL reported $2.64B in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Arca Biopharma USD -34.43M 326K Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Bio Path USD -488K 4.07M Sep/2025
Brainstorm Cell Therapeutics USD -2.05M 526K Sep/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
TherapeuticsMD USD -1.77M 699K Sep/2023